Industry News
Pharmaceutical Industry News
ICER says Pfizer’s Paxlovid, Merck’s molnupiravir both cost effective, but their benefits are far from equal
ICER says Pfizer's Paxlovid, Merck's molnupiravir both cost effective, but their benefits are far from equal fkansteiner Tue, 05/10/2022 - 09:00
Sun Pharma facility dinged with notice of deficiencies after visit from FDA inspectors
Sun Pharma facility dinged with notice of deficiencies after visit from FDA inspectors jkeenan Tue, 05/10/2022 - 08:25
Moderna mounts defense in COVID-19 vaccine patent feud with Arbutus, Genevant
Moderna mounts defense in COVID-19 vaccine patent feud with Arbutus, Genevant fkansteiner Tue, 05/10/2022 - 07:53
Stevanato inks auto-injector deal to continue drug delivery push
Stevanato inks auto-injector deal to continue drug delivery push ntaylor Tue, 05/10/2022 - 07:02
Petros picks 505(b)(2) pathway for topical rival to Endo therapy
Petros picks 505(b)(2) pathway for topical rival to Endo therapy ntaylor Tue, 05/10/2022 - 06:58
AstraZeneca, FibroGen can’t agree on roxadustat’s path forward in chronic kidney disease after FDA rejection
AstraZeneca, FibroGen can't agree on roxadustat's path forward in chronic kidney disease after FDA rejection aliu Tue, 05/10/2022 - 06:00
Bristol Myers Squibb goes all out on unbranded campaigns for newly approved $13B drug Camzyos
Bristol Myers Squibb goes all out on unbranded campaigns for newly approved $13B drug Camzyos badams Tue, 05/10/2022 - 04:46
Biomanufacturing player eureKING emerges with star-studded roster of Sanofi, Bayer vets in tow
Biomanufacturing player eureKING emerges with star-studded roster of Sanofi, Bayer vets in tow fkansteiner Mon, 05/09/2022 - 13:50
Viatris warns war in Ukraine could squeeze future financials
Viatris warns war in Ukraine could squeeze future financials fkansteiner Mon, 05/09/2022 - 11:07
BioNTech trumpets strong sales, but pandemic ‘uncertainty’ still suggests a decline in 2022
BioNTech trumpets strong sales, but pandemic 'uncertainty' still suggests a decline in 2022 fkansteiner Mon, 05/09/2022 - 10:20
ADC Therapeutics taps Novartis vet Mallik as its next CEO, replacing cofounder Martin
ADC Therapeutics taps Novartis vet Mallik as its next CEO, replacing cofounder Martin zbecker Mon, 05/09/2022 - 09:27
ADC Therapeutics taps Novartis vet Ameet Mallik as its next CEO, replacing co-founder Martin
ADC Therapeutics taps Novartis vet Ameet Mallik as its next CEO, replacing co-founder Martin zbecker Mon, 05/09/2022 - 09:27
UPDATED: Seagen CEO Clay Siegall put on leave after domestic violence arrest
UPDATED: Seagen CEO Clay Siegall put on leave after domestic violence arrest aliu Mon, 05/09/2022 - 08:33
Seeking Covid Pills, Poor Nations Fear Repeat of AIDS Crisis
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.
Idorsia’s insomnia drug Quviviq hits the market with 500 sales reps and plans for ‘robust’ DTC campaign
Idorsia's insomnia drug Quviviq hits the market with 500 sales reps and plans for 'robust' DTC campaign nmissakian Sat, 05/07/2022 - 17:09
After 2 years, Sanofi’s drug ingredients spinoff takes flight
After 2 years, Sanofi's drug ingredients spinoff takes flight fkansteiner Fri, 05/06/2022 - 09:59
AstraZeneca, GSK’s cancer rival Clovis quietly unveils crippling FDA delay as its troubles deepen
AstraZeneca, GSK's cancer rival Clovis quietly unveils crippling FDA delay as its troubles deepen aliu Fri, 05/06/2022 - 09:42
Back where it started: FDA restricts use of J&J’s COVID-19 shot because of blood clot threat
Back where it started: FDA restricts use of J&J's COVID-19 shot because of blood clot threat kdunleavy Fri, 05/06/2022 - 09:16
Gerresheimer invests in Portal’s needle-free drug delivery, teeing Takeda partner up to advance tech
Gerresheimer invests in Portal's needle-free drug delivery, teeing Takeda partner up to advance tech ntaylor Fri, 05/06/2022 - 09:09
Vertex, riding high on Trikafta, isn’t just a rare disease company, execs say
Vertex, riding high on Trikafta, isn't just a rare disease company, execs say fkansteiner Fri, 05/06/2022 - 07:57